MEDSECUREAN.COM

Lobbying for LUPIN PHARMACEUTICALS · Lupin Pharmaceuticals is a generic manufacturing company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Florida · Senate · $42,000.00 income · posted Feb 14, 2026

Lobbying activity 2

Health Issues

Generic Industry Sustainability and tariifs broadly.

Trade (domestic/foreign)

Tarrifs - generic medicine

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.